Search research articles
Contact Us
Filters
Showing results (141-150 of 144) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 144 results.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
December 1, 1988
Cardiopulmonary resuscitation in the rat
I von Planta, M H Weil, M von Planta, et al.
Critical Care Medicine
|
November 1, 1983
Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock
E C Rackow, J L Falk, I A Fein, et al.
Critical Care Medicine
|
January 1, 1995
Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial
M E Astiz, E C Rackow, J G Still, et al.
JAMA
|
June 15, 1994
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group
C J Fisher, J F Dhainaut, S M Opal, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 144) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 144 results.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
December 1, 1988
Cardiopulmonary resuscitation in the rat
I von Planta, M H Weil, M von Planta, et al.
Critical Care Medicine
|
November 1, 1983
Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock
E C Rackow, J L Falk, I A Fein, et al.
Critical Care Medicine
|
January 1, 1995
Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial
M E Astiz, E C Rackow, J G Still, et al.
JAMA
|
June 15, 1994
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group
C J Fisher, J F Dhainaut, S M Opal, et al.
Page
of 15